| Original language | English |
|---|---|
| Title of host publication | Inflammation and Allergy Drug Design |
| Publisher | Wiley-Blackwell |
| Pages | 237-252 |
| Number of pages | 16 |
| ISBN (Print) | 9781444330144 |
| DOIs | |
| State | Published - 27 Jul 2011 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Airway hyperresponsiveness (AHR) - component of asthma, optimal anti-inflammatory therapy
- Airway remodeling, prominent pathophysiologic - feature of chronic asthma
- Asthma and airway fibrosis - increase in fibroblasts, differentiation of myofibroblasts in asthma
- Attenuation of angiogenesis - and cancer therapies, VEGF pathway as key regulator of angiogenesis
- Eosinophils and angiogenesis - eosinophil contribution to angiogenesis, in asthma
- Interleukin 4 and interleukin 13 - cytokines from Th2 cells, mediators in asthma
- Nerve growth factor (NGF), important neurotrophic agent - produced in airways
- Profibrotic and - angiogenic factors in asthma
- Transforming growth factor beta - TGF-β superfamily, over 30 different proteins and BMPs
- Transforming growth factor beta - critical for embryogenesis and tissue repair, role in mediating immune responses
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver